NDC product
Glipizide and Metformin Hydrochloride
NDC 0179-0205 · KAISER FOUNDATION HOSPITALS
Key facts
| Product NDC | 0179-0205 |
|---|---|
| Proprietary name | Glipizide and Metformin Hydrochloride |
| Labeler | KAISER FOUNDATION HOSPITALS |
| Marketing category | ANDA |
| Application number | ANDA077270 |
| Marketing start | Apr 22, 2016 |
| Marketing end | Jan 31, 2020 |
| Listing certified through | Jan 31, 2020 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: